Neglected infection control is better investment than nuclear weaponry

Apr 27, 2010

For a tiny fraction of the cost of maintaining a nuclear arsenal, the 11 nuclear power states (United States, Russia, United Kingdom, France, China, India, Pakistan, North Korea, Israel, Iran, and possibly Syria) could eliminate neglected infections within their borders—which account for up to 50% of the global disease burden—and beyond, says a new editorial published April 27 in the open-access journal PLoS Neglected Tropical Diseases.

In his analysis, "Nuclear Weapons and Neglected Diseases: The 'Ten-Thousand-to-One Gap," Dr. Peter Hotez, President of the Sabin Vaccine Institute and Distinguished Research Professor at The George Washington University Medical Center, estimates that "the 11 nuclear weapons states together have invested at least $10 trillion on weapons production and maintenance" while "the costs for both neglected disease control and R&D come close to $1 billion, or roughly less than 1/10,000th of the estimated $10 trillion committed for nuclear weapons."

With the possible exception of the United Kingdom, each of the nuclear weapons states has a high neglected disease burden.

  • India accounts for roughly one-quarter of the world's 120 million cases of lymphatic filariasis, a disfiguring and stigmatizing vector-borne infection associated with elephantiasis.
  • Almost one-half of the world's 60 million trachoma cases occur in nuclear weapons states, with China having the highest number of cases of any nation.
  • Approximately one-third of the estimated 800 million ascariasis infection cases occur in nuclear weapons states, including India (140 million), China (86 million), North Korea (8 million), Pakistan (7 million), and Iran (5 million).
Investments in nuclear weaponry are carried out under the auspice of deterring war and thus promoting peace, says Hotez, but these and additional benefits can be achieved through neglected disease funding. Increased investments in neglected disease research could control or eliminate neglected infections, support achievement of the Millennium Development Goals, stabilize and build nations, and reduce civil strife and international tensions.

"Great efforts are needed to engage leaders of the states in a frank dialogue about reallocation of resources toward public health and scientific pursuits for neglected tropical disease R&D and control," says Hotez.

"In the coming decade, engaging the nuclear powers on neglected disease R&D and global implementation efforts [would] represent a significant diplomatic victory for the world," he concludes in the editorial.

Explore further: 'Ebola will return', veteran scientist warns

More information: Hotez PJ (2010) Nuclear Weapons and Neglected Diseases: The ''Ten-Thousand-to-One Gap''. PLoS Negl Trop Dis 4(4): e680. doi:10.1371/journal.pntd.0000680

Related Stories

U. S. envisions a new generation of nuclear weapons

Mar 19, 2007

Almost 62 years after detonation of the first atomic bombs, the United States is considering controversial proposals to produce a new generation of nuclear weapons and revamp its nuclear weapons complex, according to an article ...

Recommended for you

'Ebola will return', veteran scientist warns

2 hours ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

17 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

croghan27
Apr 28, 2010
This comment has been removed by a moderator.
MikeLisanke
3 / 5 (1) May 03, 2010
Interesting and unexpected political (social policy) view. Its difficult to imagine who actually pulls the strings in our (US) representative democracy. Americans aren't given decisions about monies spent on defense, entitlements, interest on the national debt. We're told what proportion of our gross national product these represent, and just expect somebody to seize a greater proportion next year.

Those who wrote the article didn't indicate how best to get their agenda considered.
croghan27
not rated yet May 03, 2010
Has not this been known for some time ... that the return on any investment in the health of the world will easily eclipse any investment war related business.

This is so not only in humanitarian terms, but in financial as well.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.